Hepatic DsbA‐L Protects Mice from Diet‐induced Hepatosteatosis and Insulin Resistance
Hongzhi Chen,Juli Bai,Feng Dong,Hezhi Fang,Yun Zhang,Wen Meng,Bilian Liu,Yan Luo,Meilian Liu,Yidong Bai,Muhammad A Abdul-Ghani,Rongxia Li,Jiarui Wu,Rong Zeng,Zhiguang Zhou,Lily Q Dong,Feng Liu
DOI: https://doi.org/10.1096/fj.201600985r
2017-01-01
Abstract:Hepatic insulin resistance and hepatosteatosis in diet-induced obesity are associated with various metabolic diseases, yet the underlying mechanisms remain to be fully elucidated. Here we show that the expression levels of the disulfide-bond A oxidoreductase-like protein (DsbA-L) are significantly reduced in the liver of obese mice and humans. Liver-specific knockout or adenovirus-mediated overexpression of DsbA-L exacerbates or alleviates, respectively, high-fat diet-induced mitochondrial dysfunction, hepatosteatosis, and insulin resistance in mice. Mechanistically, we found that DsbA-L is localized in mitochondria and that its deficiency is associated with impairment of maximum respiratory capacity, elevated cellular oxidative stress, and increased JNK activity. Our results identify DsbA-L as a critical regulator of mitochondrial function, and its down-regulation in the liver may contribute to obesity-induced hepatosteatosis and whole body insulin resistance.-Chen, H., Bai, J., Dong, F., Fang, H., Zhang, Y., Meng, W., Liu, B., Luo, Y., Liu, M., Bai, Y., Abdul-Ghani, M. A., Li, R., Wu, J., Zeng, R., Zhou, Z., Dong, L. Q., Liu, F. Hepatic DsbA-L protects mice from diet-induced hepatosteatosis and insulin resistance.